![David Caron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. David Caron is Vice President-CMC & Pharmaceutical Development at Chiasma, Inc.
Dr. Caron was previously employed as Head-Formulation by Perio Products Ltd., a Principal by Merck Generics, Section Manager by Teva Pharmaceuticals USA, Inc., and Senior Director-CMC & Quality Assurance by Aposense Ltd.
He received his doctorate degree from Université Claude Bernard Lyon 1.
| Companies | Position | End |
|---|---|---|
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Corporate Officer/Principal | - |
Perio Products Ltd.
 Perio Products Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
| APOSENSE LTD | Corporate Officer/Principal | - |
Merck Generics | Corporate Officer/Principal | - |
| CHIASMA, INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 6 |
|---|---|
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Health Technology |
Université Claude Bernard Lyon 1
 Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aposense Ltd.
 Aposense Ltd. Pharmaceuticals: MajorHealth Technology Operates as a molecular imaging and drug development company | Health Technology |
Merck Generics | |
Perio Products Ltd.
Perio Products Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
